Valuation: Alembic Pharmaceuticals Limited

Market Cap 158B 1.66B 1.42B 1.33B 1.21B 2.29B 2.31B 15.68B 6.11B 79.64B 6.22B 6.08B 264B P/E 2027 *
21.7x
P/E 2028 * 16.7x
Enterprise Value 168B 1.77B 1.51B 1.42B 1.29B 2.44B 2.47B 16.72B 6.51B 84.92B 6.63B 6.48B 281B EV / Sales 2027 *
2x
EV / Sales 2028 * 1.73x
Free-Float
29.33%
Yield 2027 *
1.6%
Yield 2028 * 1.9%
1 day+1.00%
1 week-0.78%
Current month+1.77%
1 month-0.41%
3 months+6.79%
6 months+11.18%
Current year-4.14%
1 week 801.05
Extreme 801.05
826.8
1 month 792.55
Extreme 792.55
855.9
Current year 635.8
Extreme 635.8
855.9
1 year 635.8
Extreme 635.8
998
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 07/07/2025
Compliance Officer - 20/08/2026
Chief Operating Officer - 21/07/2025
Director TitleAgeSince
Chairman 78 08/06/2012
Director/Board Member 50 01/01/2007
Director/Board Member 66 18/01/2003
Date Insider Type Main position Quantity % Market Cap.
28/03/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
24/03/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
21/03/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+1.21%-0.78%-13.38%+8.14% 1.66B
-1.06%+0.65%+77.42%+122.82% 1,100B
+0.53%+0.75%+53.10%+64.29% 658B
+0.48%+2.65%+28.06%+81.19% 470B
+0.92%+3.57%+43.82%+44.21% 372B
+1.25%+2.21%+26.77%+43.05% 304B
+3.02%+5.68%+4.24%+17.04% 264B
-0.36%+3.99%+53.31%+72.49% 239B
+2.86%+3.86%-16.20%-51.83% 213B
+1.38%+3.72%+30.33%+93.56% 184B
Average +1.00%+2.45%+28.75%+49.50% 380.45B
Weighted average by Cap. +0.45%+2.21%+45.65%+71.78%

Financials

2027 *2028 *
Net sales 84.17B 883M 757M 709M 648M 1.22B 1.23B 8.36B 3.26B 42.47B 3.32B 3.24B 141B 92.45B 970M 831M 779M 711M 1.34B 1.36B 9.18B 3.58B 46.64B 3.64B 3.56B 154B
Net income 7.32B 76.77M 65.79M 61.64M 56.31M 106M 107M 727M 283M 3.69B 288M 282M 12.23B 9.48B 99.4M 85.18M 79.81M 72.91M 138M 139M 941M 367M 4.78B 373M 365M 15.83B
Net Debt 10.45B 110M 93.93M 88.02M 80.4M 152M 153M 1.04B 404M 5.27B 412M 403M 17.46B 1.91B 20.09M 17.21M 16.13M 14.73M 27.8M 28.08M 190M 74.06M 966M 75.42M 73.77M 3.2B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
26/08/26 812.85 +1.21% 7,538
25/08/26 ₹803.10 -1.69% 37,809
24/08/26 ₹816.90 -0.59% 39,308
21/08/26 ₹821.75 +0.94% 35,565
20/08/26 ₹814.10 -0.42% 47,603
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
803.10INR
Average target price
949.30INR
Spread / Average Target
+18.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock